Skip to main content
. 2020 Jun 29;11(8):2196–2208. doi: 10.1111/1759-7714.13527

Figure 6.

Figure 6

The target relationship between miR‐519d‐3p and HMGB1. (a) The StarBase algorithms showed the complementary binding sequence of miR‐519d‐3p on the wild‐type of HMGB1 3'UTR (HMGB1 3'UTR WT). The mutant type of HMGB1 3'UTR (HMGB1 3'UTR MUT) was constructed. 3'UTR, 3' untranslated region. (b and c) Dual‐luciferase reporter assay evaluated relative luciferase activity of HMGB1 3'UTR WT/MUT in A549 and H1975 cells transfected with miR‐519d‐3p or miR‐NC (Inline graphic) miR‐NC, (Inline graphic) miR‐519d‐3p; () miR‐NC, ()miR‐519d‐3p. (d and e) Western blotting confirmed the expression of HMGB1 protein in (d) three paired tissues (Normal and Tumor groups), and (e) 16HBE, A549 and H1975 cells. (f) RT‐qPCR detected miR‐519d‐3p expression in A549 and H1975 cells transfected with miR‐519d‐3p or miR‐NC (Inline graphic) miR‐NC, (Inline graphic) miR‐519d‐3p. (g and h) Western blotting examined HMGB1 protein expression in A549 and H1975 cells transfected with anti‐NC, anti‐miR‐519d‐3p, miR‐NC, or miR‐519d‐3p. (i and j) Western blotting examined HMGB1 protein expression in A549 and H1975 cells transfected with sh‐NC or sh‐circ, and cotransfected with sh‐circ and anti‐NC or anti‐miR‐519d‐3p. **P < 0.01.